Menstrual cycle-related changes in circulating androgens in healthy women with self-reported normal sexual function

Journal of Sexual Medicine

Volumn 5, Issue 4, 2008, Pages 854-863

  Salonia, Andrea ^a   Pontillo, Marina ^a   Nappi, Rossella E ^b   Zanni, Giuseppe ^a   Fabbri, Fabio ^a   Scavini, Marina ^a   Daverio, Rita ^a   Gallina, Andrea ^a   Rigatti, Patrizio ^a   Bosi, Emanuele ^a   Bonini, Pier Angelo ^a   Montorsi, Francesco ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF PAVIA   (Italy)

Author keywords

Androgens; Female Women; Sexual Dysfunction; Sexual Function; Testosterone

Indexed keywords

ANDROSTENEDIONE; PRASTERONE SULFATE; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ANDROSTENEDIONE BLOOD LEVEL; ARTICLE; BECK DEPRESSION INVENTORY; FEMALE; FOLLICULAR PHASE; HORMONAL REGULATION; HUMAN; LUTEAL PHASE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; OVARY CYCLE; PRIORITY JOURNAL; QUESTIONNAIRE; SELF REPORT; SEXUAL FUNCTION; TESTOSTERONE BLOOD LEVEL;

EID: 41549116412     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2008.00791.x     Document Type: Article

References (51)

1. Bachmann G, Bancroft J, Braunstein G, Burger H, Davis S, Dennerstein L, Goldstein I, Guay A, Leiblum S, Lobo R, Notevolitz M, Rosen RC, Sarrel P, Sherwin B, Simon J, Simpson E, Shifren J, Spark R, Traish A. Female androgen insufficiency: The Princeton consensus statement on definition, classification, and assessment. Fertil Steril 2002; 77: 660-5.
2. Wierman ME, Basson R, Davis SR, Khosla S, Miller KK, Rosner W, Santoro N. Androgen therapy in women: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2006; 91: 3697-710.
3. Kingsberg S. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women. J Sex Med 2007; 4 (3 suppl): 227-34.
4. Miller KK, Rosner W, Lee H, Hier J, Sesmilo G, Schoenfeld D, Neubauer G, Klibanski A. Measurement of free testosterone in normal women and women with androgen deficiency: Comparison of methods. J Clin Endocrinol Metab 2004; 89: 525-33.
5. Cameron DR, Braunstein GD. Androgen replacement therapy in women. Fertil Steril 2004; 82: 273-89.
6. Shifren JL, Davis SR, Moreau M, Waldbaum A, Bouchard C, DeRogatis L, Derzko C, Bearnson P, Kakos N, O'Neill S, Levine S, Wekselman K, Buch A, Rodenberg C, Kroll R. Testosterone patch for the treatment of hypoactive sexual desire disorder in naturally menopausal women: Results from the INTIMATE NM1 Study. Menopause 2006; 13: 770-9.
7. Shifren JL, Braunstein GD, Simon JA, Casson PR, Buster JE, Redmond GP, Burki RE, Ginsburg ES, Rosen RC, Leiblum SR, Caramelli KE, Mazer NA. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343: 682-8.
8. Simon J, Braunstein G, Nachtigall L, Utian W, Katz M, Miller S, Waldbaum Bouchard C, Derzko C, Buch A, Rodenberg C, Lucas J, Davis S. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder. J Clin Endocrinol Metab 2005; 90: 5226-33.
9. Miller KK, Biller BM, Beauregard C, Lipman JG, Jones J, Schoenfeld D, Sherman JC, Swearingen B, Loeffler J, Klibanski A. Effects of testosterone replacement in androgen-deficient women with hypopituitarism: A randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 2006; 91: 1683-90.
10. Braunstein GD, Sundwall DA, Katz M, Shifren JL, Buster JE, Simon JA, Bachman G, Aguirre OA, Lucas JD, Rodenberg C, Buch A, Watts NB. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: A randomized, placebo-controlled trial. Arch Intern Med 2005; 165: 1582-9.
11. North American Menopause Society. The role of testosterone therapy in postmenopausal women: Position statement of the North American Menopause Society. Menopause 2005; 12: 496-511.
12. Kingsberg S, Shifren J, Wekselman K, Rodenberg C, Koochaki P, Derogatis L. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder. J Sex Med 2007; 4: 1001-8.
13. Lazarou S, Reyes-Vallejo L, Morgentaler A. Wide variability in laboratory reference values for serum testosterone. J Sex Med 2006; 3: 1085-9.
14. Rivera-Woll LM, Papalia M, Davis SR, Burger HG. androgen insufficiency in women: Diagnostic and therapeutic implications. Hum Reprod Update 2004; 10: 421-32.
15. Bell RJ, Donath S, Davison SL, Davis SR. Endogenous androgen levels and well-being: Differences between premenopausal and postmenopausal women. Menopause 2006; 13: 65-71.
16. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS, Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: An endocrine society clinical practice guideline. J Clin Endocrinol Metab 2006; 91: 1995-2010.
17. Maggi M, Schulman C, Quinton R, Langham S, Uhl-Hochgraeber K. The burden of testosterone deficiency syndrome in adult men: Economic and quality-of-life impact. J Sex Med 2007; 4: 1056-69.
18. Davis SR, Davison SL, Donath S, Bell RJ. Circulating androgen levels and self-reported sexual function in women. JAMA 2005; 294: 91-6.
19. Guay A, Munarriz R, Jacobson J, Talakoub L, Traish A, Quirk F, Goldstein I, Spark R. Serum androgen levels in healthy premenopausal women with and without sexual dysfunction: Part A. Serum androgen levels in women aged 20-49 years with no complaints of sexual dysfunction. Int J Impot Res 2004; 16: 112-20.
20. Lamon-Fava S, Barnett JB, Woods MN, McCormack C, McNamara JR, Schaefer EJ, Longcope C, Rosner B. Gorbach SL 2005 Differences in serum hormone and plasma lipid levels in Caucasian and African-American premenopausal women. J Clin Endocrinol Metab 2005; 90: 4516-20.
21. Mushayandebvu T, Castracane VD, Gimpel T, Adel T, Santoro N. Evidence for diminished midcycle ovarian androgen production in older reproductive aged women. Fertil Steril 1996; 65: 721-3.
22. Salonia A, Lanzi R, Scavini M, Pontillo M, Gatti E, Petrella G, Licata G, Nappi RE, Bosi E, Briganti A, Rigatti P, Montorsi F. Sexual function and endocrine profile in fertile women with type 1 diabetes. Diabetes Care 2006; 29: 312-6.
23. National Committee for Clinical Laboratory Standards. How to define, determine, and utilize reference intervals in the clinical laboratory; approved guidelines. NCCLS document C28-A. Villanova PA: NCCLS; June 1995: 59.
24. Richter P, Werner J, Heerlein A, Kraus A, Sauer H. On the validity of the Beck Depression Inventory. A review. Psychopathology 1998; 31: 160-8.
25. Rosen RC, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R, Jr. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 191-208.
26. Derogatis LR, Rosen R, Leiblum S, Burnett A, Heiman J. The Female Sexual Distress Scale (FSDS): Initial validation of a standardized scale for assessment of sexually related personal distress in women. J Sex Marital Ther 2002; 28: 317-30.
27. Wiegel M, Meston C, Rosen RC. The Female Sexual Function Index (FSFI): cross-validation and development of clinical cut-off scores. J Sex Marital Ther 2005; 31: 1-20.
28. Massafra C, De Felice C, Agnusdei DP, Gioia D, Bagnoli F. Androgens and osteocalcin during the menstrual cycle. J Clin Endocrinol Metab 1999; 84: 971-4.
29. Miller KK. Androgen deficiency in women. J Clin Endocrinol Metab 2001; 86: 2395-401.
30. Zumoff B, Strain GW, Miller LK, Rosner W. Twenty-four hour mean plasma testosterone concentration declines with age in normal premenopausal women. J Clin Endocrinol Metab 1995; 80: 1429-30.
31. Labrie F, Belanger A, Cusan L, Gomez JL, Candas B. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab 1997; 82: 2396-402.
32. Davison SL, Bell R, Donath S, Montalto JG, Davis SR. Androgen levels in adult females: Changes with age, menopause, and oophorectomy. J Clin Endocrinol Metab 2005; 90: 3847-53.
33. McHorney CA, Rust J, Golombok S, Davis S, Bouchard C, Brown C, Basson R, Sarti CD, Kuznicki J, Rodenberg C, Derogatis, L. Profile of female sexual function: A patient-based, international, psychometric instrument for the assessment of hypoactive sexual desire in oophorectomized women. Menopause 2004; 11: 474-83.
34. Derogatis L, Rust J, Golombok S, Bouchard C, Nachtigall L, Rodenberg C, Kuznicki J, McHorney CA. Validation of the profile of female sexual function (PFSF) in surgically and naturally menopausal women. J Sex Marital Ther 2004; 30: 25-36.
35. Guay A, Jacobson J, Munarriz R, Traish A, Talakub L, Quirk F, Goldstein I, Spark R. Serum androgen levels in healthy premenopausal women with anR without sexual dysfunction: Part B: reduced serum androgen levels in healthy premenopausal women with complaints of sexual dysfunction. Int J Impot Res 2004; 16: 121-9.
36. Somboonporn W, Davis S, Seif MW, Bell R. Testosterone for peri- and postmenopausal women. Cochrane Database Syst Rev 2005; 4: CD004509.
37. Chudakov B, Ben Zion IZ, Belmaker RH. Transdermal testosterone gel prn application for hypoactive sexual desire disorder in premenopausal women: A controlled pilot study of the effects on the Arizona sexual experiences scale for females and sexual function questionnaire. J Sex Med 2007; 4: 204-8.
38. Lobo RA, Rosen RC, Yang HM, Block B, Van Der Hoop RG. Comparative effects of oral esterified estrogens with and without methyltestosterone on endocrine profiles and dimensions of sexual function in postmenopausal women with hypoactive sexual desire. Fertil Steril 2003; 79: 1341-52.
39. Santoro N, Torrens J, Crawford S, Allsworth JE, Finkelstein JS, Gold EB, Korenman S, Lasley WL, Luborsky JL, McConnell D, Sowers MF, Weis G. Correlates of circulating androgens in mid-life women: The Study of Women's Health across the nation. J Clin Endocrinol Metab 2005; 90: 4836-45.
40. Dennerstein L, Randolph J, Taffe J, Dudley E, Burger H. Hormones, mood, sexuality and the menopausal transition. Fertil Steril 2002; 77 (4 Suppl): S42-8.
41. Rosner W, Auchus RJ, Azziz R, Sluss PM, Raff H. Utility, limitations and pitfalls in measuring testosterone: An Endocrine Society Position Statement. J Clin Endocrinol Metab 2007; 92: 405-13.
42. Chang WY, Knochenhauer ES, Bartolucci AA, Azziz R. Phenotypic spectrum of polycystic ovary syndrome: Clinical and biochemical characterization of the three major clinical subgroups. Fertil Steril 2005; 83: 1717-23.
43. Schutter DJ, Peper JS, Koppeschaar HP, Kahn RS, van Honk J. Administration of testosterone increases functional connectivity in a cortico-cortical depression circuit. J Neuropsychiatry Clin Neurosci 2005; 17: 372-7.
44. Althof SE, Leiblum SR, Chevret-Measson M, Hartmann U, Levine SB, McCabe M, Plaut M, Rodrigues O, Wylie K. Psychological and interpersonal dimensions of sexual function and dysfunction. J Sex Med 2005; 2: 793-800.
45. Labrie F, Belanger A, Belanger P, Berube R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C, Leclaire J. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. J Steroid Biochem Mol Biol 2006; 99: 182-8.
46. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999; 84: 3666-72.
47. Pugeat M, Crave J, Tourniaire J, Forest M. Clinical utility of sex hormone-binding globulin measurement. Horm Res 1996; 45: 148-55.
48. Randolph JF, Sowers M, Gold EB, Mohr BA, Luborsky J, Santoro N, McConnell DS, Finkelstein JS, Korenman SG, Matthews KA, Sternfeld B, Lasley BL. Reproductive hormones in the early menopausal transition: relationship to ethnicity, body size, and menopausal status. J Clin Endocrinol Metab 2003; 88: 1516-22.
49. Van anders SM, Watson NV. Menstrual cycle irregularities are associated with testosterone levels in healthy premenopausal women. Am J Hum Biol 2006; 18: 841-4.
50. Dabbs JM, Jr., de La Rue D. Salivary testosterone measurements among women: Relative magnitude of circadian and menstrual cycles. Horm Res 1991; 35: 182-4.
51. Howles CM. Role of LH and FSH in ovarian function. Mol Cell Endocrinol 2000; 161: 25-30.